期刊文献+

半合成四环素在幽门螺杆菌根除中的应用 被引量:10

Application of semi-synthetic tetracycline in the eradication of Helicobacter pylori
下载PDF
导出
摘要 半合成四环素包括多西环素及米诺环素在幽门螺杆菌根除中的疗效尚不明确。药敏研究显示,幽门螺杆菌对半合成四环素的敏感性较高。临床应用中,在幽门螺杆菌感染初治患者中,含半合成四环素的三联方案根除效果并不理想;而在复治患者中,含半合成四环素的铋剂四联方案根除率令人满意。半合成四环素在根除幽门螺杆菌治疗中不良反应轻微,安全性高。目前的研究提示在幽门螺杆菌感染的根除治疗中,含半合成四环素的铋剂四联方案可能是一个有效的选择。 The efficiency of semi-synthetic tetracycline in the eradication of Helicobacter pylori (H. pylori) was unsure. It was found that H. pylori was sensitive to semi-synthetic tetracycline in vitro. In the clinical application, the eradication rates of the first-line triple therapy containing semi-synthetic tetracycline were low. But the second-line quadruple therapy containing semi-synthetic tetracycline, eradication rates were ideal. Semi-synthetic tetracycline could be safely used in the eradication ofH. pylori. It suggested that quadruple therapy containing semi-synthetic tetracycline may be a good choice for the eradication ofH. pylori.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2016年第9期647-652,共6页 Chinese Journal of Antibiotics
关键词 幽门螺杆菌 根除 半合成四环素 米诺环素 多西环素 Helicobacterpylori Eradication Semi-synthetic tetracycline Minocycline Doxycycline
  • 相关文献

参考文献35

  • 1无,刘文忠,谢勇,成虹,吕农华,胡伏莲,张万岱,周丽雅,陈烨,曾志荣,王崇文,萧树东,潘国宗,胡品津.第四次全国幽门螺杆菌感染处理共识报告[J].中华内科杂志,2012,51(10):832-837. 被引量:843
  • 2Testino G. Gastric preneoplastic changes[J]. Hecemti Prog Med, 2004, 95(5): 239-244.
  • 3周丽雅,林三仁,丁士刚,黄雪彪,郭长吉,张莉,崔荣丽,金珠,孟灵梅,张静.根除幽门螺杆菌对胃癌患病率及胃黏膜组织学变化的八年随访研究[J].中华消化杂志,2005,25(6):324-327. 被引量:87
  • 4Ando T, Ishikawa T, Takagi T, et al. Impact of Helicobacter pylori eradication on circulating adiponectin in humans[J]. Helicobacter, 2013, 18(2): 158-164.
  • 5Fischbach L, Evans E L. Meta-analysis: the effect ofantibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori[J]. Aliment Pharmacol Ther, 2007, 26(3): 343-357.
  • 6Gao W, Cheng H, Hu F, et al. The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China. [J]. Helicobacter, 2010, 15(5): 460-466.
  • 7Zhou L Y, Zhang J Z, Chen M H, et al. A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: A randomized multicenter trial[J]. Am J Gastroenterol, 2014, 109(4): 535-541.
  • 8Graham D Y, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy[J]. Helicobacter, 2007, 12(4): 275-278.
  • 9Heep M, Kist M, Strobel S, et al. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy[J]. Eur J Clin Microbiol lnfect Dis, 2000, 19(7): 538-541.
  • 10Horiki N, Omata F, Uemura M, et al. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan[J]. Helicobacter, 2009, 14(5): 86-90.

二级参考文献62

共引文献1022

同被引文献88

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部